NTD Labs: Setting the Standard in Prenatal Screening
For more than 30 years, NTD Labs has pioneered the research and development of prenatal screening protocols for open neural tube defects, Down syndrome, trisomy 18 and trisomy13. Today, NTD Labs serves universities, medical centers, hospitals, laboratories, obstetricians and maternal fetal medicine specialists worldwide; providing risk assessment services that help health care professionals and patients make more informed medical decisions.
NTD Labs maintains one of the largest maternal serum banks worldwide. Its menu of risk assessment services includes the Ultra-Screen® (free Beta hCG/PAPP-A/NT)protocol, the Ultra-Screen® protocol with Nasal Bone Assessment, and the Instant Risk Assessment (IRA) program. NTD Labs was one of the world’s first clinical laboratories to provide an AFP (alpha-fetoprotein) screening program, a service that identifies risk for open neural tube defects (NTD) which it still provides today.
Annually, NTD processes hundreds of thousands of maternal blood specimens using specially designed analytical workflow cycles and immunoassay systems that ensure accurate testing and documentation, efficient specimen handling and reporting.
To learn more about NTD Labs and its innovative risk assessment testing protocols, Contact Us today.